Cargando…

Real-world impact of postmastectomy radiotherapy in T1–2 breast cancer with one to three positive lymph nodes

BACKGROUND: The utility of postmastectomy radiotherapy (PMRT) in breast cancer patients with T1–2 (tumor size ≤5 cm) and N1 (one to three lymph nodes involved) disease remains controversial. The aim of this population-based study was to investigate the effectiveness of PMRT in this patient subset in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Feng-Yan, Lian, Chen-Lu, Lei, Jian, Wang, Jun, Hua, Li, He, Zhen-Yu, Wu, San-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210210/ https://www.ncbi.nlm.nih.gov/pubmed/32395533 http://dx.doi.org/10.21037/atm.2020.03.49

Ejemplares similares

Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy
por: Wu, San-Gang, et al.
Publicado: (2014)

The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer
por: Zhang, Lei, et al.
Publicado: (2020)

Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1–3 positive lymph nodes: a retrospective study
por: Chitapanarux, Imjai, et al.
Publicado: (2014)

Number of Negative Lymph Nodes Can Predict Survival after Postmastectomy Radiotherapy According to Different Breast Cancer Subtypes
por: Wu, San-Gang, et al.
Publicado: (2015)

Is Postmastectomy Radiotherapy Really Needed in Breast Cancer Patients with Many Positive Axillary Lymph Nodes?
por: Marinko, Tanja, et al.
Publicado: (2018)

Effects of postmastectomy radiotherapy on prognosis in different tumor stages of breast cancer patients with positive axillary lymph nodes
por: Jia, Miao-Miao, et al.
Publicado: (2014)

Lymph node ratio may predict the benefit of postoperative radiotherapy in node-positive cervical cancer
por: Zhou, Juan, et al.
Publicado: (2016)

Impact of AJCC prognostic staging on prognosis and postmastectomy radiotherapy decision-making in hormone receptor-positive and HER2-positive breast cancer
por: Li, Guan-Qiao, et al.
Publicado: (2022)

Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes
por: He, Zhen-Yu, et al.
Publicado: (2015)

Correction: Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes
por: He, Zhen-Yu, et al.
Publicado: (2015)

Impact of the 21-gene expression assay on treatment decisions and clinical outcomes in breast cancer with one to three positive lymph nodes
por: Li, Guan-Qiao, et al.
Publicado: (2023)

Dosimetric Comparison of Postmastectomy Radiotherapy Plans for Synchronous Bilateral Breast Cancer, Including Regional Lymph Node Irradiation
por: Wu, Xiuxiu, et al.
Publicado: (2023)

Post‐mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes
por: Verma, Rashmi, et al.
Publicado: (2023)

Clinical decision making in postmastectomy radiotherapy in node negative breast cancer
por: Barrientos, Rodrigo, et al.
Publicado: (2018)

Effect of postmastectomy radiotherapy on triple-negative breast cancer with T1-2 and 1-3 positive axillary lymph nodes: a population-based study using the SEER 18 database
por: Zhang, Jie, et al.
Publicado: (2019)

Evidence-Based Analysis of Lymph Node Transfer in Postmastectomy Upper Extremity Lymphedema
por: Sapountzis, Stamatis, et al.
Publicado: (2013)

Role of postmastectomy radiation therapy in breast cancer patients with T1–2 and 1–3 positive lymph nodes
por: Cihan, Yasemin Benderli, et al.
Publicado: (2016)

Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes
por: Yin, Hang, et al.
Publicado: (2017)

Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes
por: Kim, S I, et al.
Publicado: (2013)

Postmastectomy radiotherapy using three different techniques: a retrospective evaluation of the incidental dose distribution in the internal mammary nodes
por: Wang, Wei, et al.
Publicado: (2019)

Patterns of postmastectomy radiation therapy in clinically node-positive breast cancer patients with pathologically negative lymph nodes after neoadjuvant chemotherapy
por: SAYAN, Mutlay, et al.
Publicado: (2021)

Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?
por: Lai, Shih-Fan, et al.
Publicado: (2019)

A Prognostic Risk Stratification Model to Identify Potential Population Benefiting From Postmastectomy Radiotherapy in T1–2 Breast Cancer With 1–3 Positive Axillary Lymph Nodes
por: Hou, Niuniu, et al.
Publicado: (2021)

The Predictive Effect of the 8th AJCC Pathological Prognostic Staging on the Benefit of Postmastectomy Radiotherapy in N2/N3 Breast Cancer
por: Yang, Shi-Ping, et al.
Publicado: (2022)

Automated treatment planning of postmastectomy radiotherapy
por: Kisling, Kelly, et al.
Publicado: (2019)

Evaluation of Hybrid VMAT Advantages and Robustness Considering Setup Errors Using Surface Guided Dose Accumulation for Internal Lymph Mammary Nodes Irradiation of Postmastectomy Radiotherapy
por: Zhang, Zhe, et al.
Publicado: (2022)

Local and regional recurrence following mastectomy in breast cancer patients with 1–3 positive nodes: implications for postmastectomy radiotherapy volume
por: Park, Shin-Hyung, et al.
Publicado: (2018)

A Hybrid Conformal Planning Technique with Solitary Dynamic Portal for Postmastectomy Radiotherapy with Regional Nodes
por: Rafic, K. Mohamathu, et al.
Publicado: (2017)

Stereotactic Body Radiotherapy for Lymph Node Oligometastases: Real-World Evidence From 90 Consecutive Patients
por: Burkon, Petr, et al.
Publicado: (2021)

Analysis of Breast Cancer Patients with T1-2 Tumors and 1-3 Positive Lymph Nodes Treated with or without Postmastectomy Radiation Therapy
por: Gilmore, Richard C., et al.
Publicado: (2020)

Which Patients Might Benefit from Postmastectomy Radiotherapy in Breast Cancer Patients with T1-2 Tumor and 1-3 Axillary Lymph Nodes Metastasis?
por: Kong, Moonkyoo, et al.
Publicado: (2013)

Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes
por: Zhang, Wei, et al.
Publicado: (2020)

Application of thermoplastic elastomer (TPE) bolus in postmastectomy radiotherapy
por: Gong, Pan, et al.
Publicado: (2022)

Incorporation of the number of positive lymph nodes leads to better prognostic discrimination of node-positive early stage cervical cancer
por: Zhou, Juan, et al.
Publicado: (2017)

Impact of the number of resected lymph nodes on survival after preoperative radiotherapy for esophageal cancer
por: Wu, San-Gang, et al.
Publicado: (2016)

Risk of Positive Sentinel Lymph Node After Neoadjuvant Systemic Therapy in Clinically Node-Negative Breast Cancer: Implications for Postmastectomy Radiation Therapy and Immediate Breast Reconstruction
por: Samiei, S., et al.
Publicado: (2019)

Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: Is there a role for radiation therapy?
por: Cosar, Rusen, et al.
Publicado: (2011)

Postoperative radiotherapy for supraglottic cancer on real-world data: can we reduce dose to lymph node levels?
por: Xu, Yi, et al.
Publicado: (2023)

Postmastectomy Radiation Therapy in Patients With Minimally Involved Lymph Nodes: A Review of the Current Data and Future Directions
por: Jang, Bum-Sup, et al.
Publicado: (2022)

The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB
por: Liu, Jieqiong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8cv4hajp371m5ln4cmb3742m5p